Squarepoint
CELG

Squarepoint’s Celgene Corp CELG Stock Holding History

Squarepoint’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-5,241
Closed -$520K – 2997
2019
Q3 		$520K Sell
5,241
-983,097
-99% -$93.4M ﹤0.01% 1597
2019
Q2 		$91.4M Buy
+988,338
New +$93.9M 0.89% 3
2019
Q1 		– Sell
-458,871
Closed -$29.4M – 2626
2018
Q4 		$29.4M Buy
458,871
+337,381
+278% +$24.9M 0.34% 42
2018
Q3 		$10.9M Buy
121,490
+31,972
+36% +$2.83M 0.13% 201
2018
Q2 		$7.11M Buy
89,518
+11,873
+15% +$986K 0.09% 318
2018
Q1 		$6.93M Sell
77,645
-10,019
-11% -$962K 0.11% 244
2017
Q4 		$9.15M Buy
+87,664
New +$9.89M 0.16% 138
2017
Q2 		– Sell
-4,283
Closed -$533K – 2053
2017
Q1 		$533K Buy
+4,283
New +$513K 0.01% 834
2016
Q4 		– Sell
-38,845
Closed -$4.06M – 2047
2016
Q3 		$4.06M Buy
+38,845
New +$4.2M 0.27% 85
2016
Q2 		– Sell
-27,768
Closed -$2.78M – 1531
2016
Q1 		$2.78M Buy
+27,768
New +$2.86M 0.22% 102

Other funds holding CELG

HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Squarepoint's CELG Position: Q4 2019 in Review

Squarepoint sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 5,241 shares — an estimated $520K sold.

Squarepoint first reported a position in CELG in Q1 2016 and held it in 10 quarters. The position peaked at $91.4M in Q2 2019. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Squarepoint reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Squarepoint sold 5,241 Celgene Corp shares in Q4 2019, an estimated $520K.
  • Squarepoint first reported a position in Celgene Corp in Q1 2016 and held it in 10 quarters.
  • Squarepoint's Celgene Corp position peaked at $91.4M in Q2 2019.
  • 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Squarepoint's 13F filing for Q4 2019, filed 14 Feb 2020.